About Careers Internship MedBlog Contact us

Cancer Research Breakthrough Raises Hope for Patients

by VR Sreeraman on November 17, 2008 at 5:38 PM
 Cancer Research Breakthrough Raises Hope for Patients

Research on cancer drug is entering a whole new era, which will lead to more successful drugs for patients, according to a charity.

Experts at Cancer Research UK have said that improved knowledge of cancer's biology means 18 percent of new drugs, compared to 5 percent previously - will become standard treatments.


The hunt for cancer drugs is conducted on a large scale, but there is also a massive failure rate, as promising candidates fall by the wayside in clinical trials.

Although scientists can learn lessons even from expensive failures, this costs drug firms and charities such as Cancer Research UK many millions.

Now, it is hoped that many of them will be alternatives to conventional chemotherapy, which can have unpleasant and dangerous side-effects, targeting the mechanisms of cancer cells more directly, with less damage to healthy cells.

"This clearly demonstrates the benefits of developing molecularly targeted treatments for cancer - understanding more about the basic biology of cancer is making a real difference to the success rate for new anti-cancer drug development," BBC quoted Dr Ian Walker, the licensing manager at the charity's commercial development arm, as saying.

However, Professor Herbie Newell, from Cancer Research UK, said that minimising the number of 'failures' could be helped if researchers and drug companies were more open about what worked, and what did not.

"We strongly believe that both industry and academia must improve the availability of data related to failed as well as successful drug development programmes," Newell said.

"The sharing of such information can only be beneficial for clinical, scientific and commercial reasons - and will help measure our progress as well as pinpoint areas for improvement," Newell added.

The research was published in the journal Nature Reviews Drug Discovery.

Source: ANI
Font : A-A+



Recommended Readings

Latest Drug News

Promising ALS Drug Candidate Extends Lifespan
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-Calvulanate Vs Amoxicillin Preference in Child Sinusitis Treatment
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
ADHD Medication Errors Surge by Nearly 300%
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
Unknown Medication Side Effects Reported by 52% of Indian Families
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
Painkillers With Hormonal Contraception Linked to Blood Clot Risk
Women using hormonal contraception, along with their healthcare providers, should explore alternative pain relief options instead of NSAIDs.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Cancer Research Breakthrough Raises Hope for Patients Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests